ArticleJournal of personalized medicine2022

TRIM24 Expression as an Independent Biomarker for Prognosis and Tumor Recurrence in HNSCC.

Luise Klapper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.